Stockreport

JCR Pharmaceuticals Announces Completion of Clinical Trial Notification Process in Japan for Phase I Study of JR-441 for Mucopolysaccharidosis Type IIIA [Yahoo! Finance]

ITOCHU CORP UNSP/ADR  (ITOCY) 
NASDAQ:AMEX Investor Relations: itochu.co.jp/en/ir/index.html
PDF the completion of the regulatory review by the Pharmaceuticals and Medical Devices Agency (PMDA) for the clinical trial notification for the Phase I study of JR-441 in i [Read more]